Serocit 46.7% Injection
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Sodium Citrate (46.7%)
Overview Serocit 46.7% Injection
Mucolytic injection, Serocit 46.7%, effectively manages respiratory conditions characterized by excessive mucus buildup. This medication facilitates easier expectoration by reducing mucus viscosity in the nasal passages, trachea, and lungs. Administration may coincide with meals or be taken independently, though adhering to prescribed dosage and duration is crucial. Prior to commencing treatment, patients with pre-existing hepatic, renal, or gastrointestinal ailments should consult their physician. While severe adverse reactions are infrequent, prolonged use might occasionally induce diarrhea.
Uses of Serocit 46.7% Injection
Conditions affecting the airways characterized by thick mucus.
Major Benefits of Serocit 46.7% Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Serocit 46.7% Injection:
- No common side effects seen
How to use Serocit 46.7% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Serocit 46.7% Injection works:
Mucolytic injection Serocit (46.7% solution) facilitates the expectoration of respiratory mucus by reducing its viscosity, thereby easing its removal from the nasal passages, trachea, and lungs.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Serocit 46.7% Injection is hazardous.
PregnancyUNSAFE
Administering Serocit 46.7% Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use; research in animal and human subjects has revealed considerable adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Serocit 46.7% Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
The administration of Serocit 46.7% Injection typically does not impair driving ability.
KidneyUNSAFE
The use of Serocit 46.7% Injection is likely inadvisable for individuals with renal impairment and should be avoided. Medical advice is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Serocit 46.7% Injection in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Serocit 46.7% Injection :
NA
Facts to Know About Serocit 46.7% Injection
| Label | Value |
|---|---|
| Chemical Type | Tricarboxylate Derivatives |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action Class | Expectorants |
3,018 People bought this recently
